The Middle East is all set to host its only forum for the global pharma and biotech industries, Pharmaceutical Manufacturing and Biotechnology Middle East, from April 27 to 29, 2008. Organised under the aegis of IIR, this conference cum exhibition event will be held at Dubai. Companies from around the globe are expected to participate in this mega pharma event.
According to the organisers, Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) is held with an objective of attracting the global pharmaceutical manufacturing industry to the Middle East. The regional pharma companies have already gained significant investments especially into the established markets such as the Levant, North Africa, Iran and GCC states. PABME 2008 is expected to apprise the global pharma companies of developments taking place in the Middle East pharma industry and pave way for possible synergies. Presently, more than 450 pharmaceutical manufacturers are operating in the Middle East and the market is valued at over US $18 billion. This market is growing at a rate of 10 per cent per annum.
"The show will be instrumental to help the exhibiting companies to find major investors to finance some of the key biotechnology research projects awaiting breakthrough for medical sciences industry worldwide," the organisers said.
Dr B R Shetty, MD and CEO, Neopharma, said, "PABME 2008 is like a shot in the arm for Middle East pharmaceutical manufacturers. This will be a right platform for companies such as Neopharma UAE to showcase, share and discuss the region's world-class manufacturing prowess".
Though the biotechnology market in the Middle East is only of US $10 billion, it is growing at 15-18 per cent per annum. The industry is attracting large amounts of private and public investment from all over the world. Middle east can also boast of Dubiotech, the region's first dedicated biotechnology research park covering 30 million square feet. According to IIR, the Middle East market for pharmaceutical manufacturing and biotechnology is valued at over US $28 billion with a double-digit growth annually.
Simon Page, director, healthcare division, IIR Middle East, said that companies from every continent have registered for PABME. "PABME will serve as the region's only networking platform for industry players to converge, network and discuss new business alliances and joint ventures. There will be conferences to discuss key issues ranging from intellectual property rights to outsourcing and contract manufacturing/research along with the exhibition. The event will be a global destination for the Pharma and Biotech industry and an opportunity not to be missed," he added.
For more details or to register visit www.pabme.com call +971 4 336 5161 or fax 971 4 336 4021.